Studies on Se incorporation in selenoproteins; effects of peroxisome proliferators and hydrogen peroxide generating system.
The objective of this study was to characterize the influence of peroxisome proliferation on the metabolism of physiological concentrations of Se. In an initial series of experiments hepatocytes in primary cultures and isolated from ordinary-fed rats, were used. The cells were exposed to 75Se-selenite (30 nM) and after 24 h the labelling of selenoproteins was analysed with SDS-PAGE. Treatments with mono(2-ethylhexyl)phthalate (MEHP; a metabolite of di(2-ethylhexyl)phthalate (DEHP)), nafenopin, decreased oxygen tension and a H2O2 generating system decreased the labelling of a 23-kDa and a 15-kDa protein. The decreased labelling of the 23- and the 15-kDa proteins was usually accompanied by an increased labelling of a 58-kDa protein. Increased oxygen tension induced uncertain effects, possibly due to toxicity. In order to further evaluate the validity of the model, the labelling was also studied in hepatocytes isolated from Se-deficient and torula yeast-fed rats. In these cells there was a decreased labelling of the 23-kDa protein as compared to cells from Se-supplemented controls when 100 nM selenite was used. In in vivo experiments it was found that a DEHP-induced decrease in glutathione peroxidase (GSH-Px) activity was potentiated by high doses of selenite. To a large extent, the labelling data are compatible with enzyme activity data and in vivo data. For example, the decreased labelling of the 23-kDa protein may reflect the decreased GSH-Px activity. It is concluded that the effects induced by MEHP on Se-labelling can be explained by an increase in the steady state level of H2O2.
Garberg
P
P
Department of Toxicology, National Institute of Occupational Health, Solna, Sweden.
Högberg
J
J
D000818:Animals; D002478:Cells, Cultured; D002995:Clofibric Acid / Q000494:pharmacology; D004051:Diethylhexyl Phthalate / Q000031:analogs & derivatives; D004591:Electrophoresis, Polyacrylamide Gel; D005947:Glucose / Q000378:metabolism; D005949:Glucose Oxidase / Q000378:metabolism; D006861:Hydrogen Peroxide / Q000378:metabolism*; D008099:Liver / Q000378:metabolism* / Q000648:ultrastructure; D008297:Male; D008830:Microbodies / Q000187:drug effects / Q000502:physiology*; D008970:Molecular Weight; D009255:Nafenopin / Q000494:pharmacology; D010100:Oxygen / Q000494:pharmacology; D011506:Proteins / Q000378:metabolism*; D051381:Rats; D012643:Selenium / Q000172:deficiency / Q000378:metabolism*; D051140:Selenoproteins
D011506:Proteins; C495241:Selenof protein, rat; D051140:Selenoproteins; D009255:Nafenopin; D002995:Clofibric Acid; D006861:Hydrogen Peroxide; D004051:Diethylhexyl Phthalate; D005949:Glucose Oxidase; C016599:mono-(2-ethylhexyl)phthalate; D012643:Selenium; D005947:Glucose; D010100:Oxygen